Open the mobile version, with barcode scanning
Class II Ongoing

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

Why: Lack of Assurance of Sterility

Company
Pfizer
Manhattan, NY, United States
Reported
Sep 23, 2026
Recall started
Sep 4, 2026
Where sold
US Nationwide.
Amount
N/A
Full product description
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
Lots / codes affected
Lot # NL5230, Exp Date:10/2027

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.